Previous Article | Next Article 
Journal of Clinical Microbiology, January 2000, p. 71-78, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Streptococcus
agalactiae Isolates of Bovine and Human Origin by Randomly
Amplified Polymorphic DNA Analysis
Gabriela
Martinez,
Josee
Harel,
Robert
Higgins,
Sonia
Lacouture,
Danielle
Daignault, and
Marcelo
Gottschalk*
Groupe de Recherche sur les Maladies
Infectieuses du Porc, Faculté de médecine
vétérinaire, Université de Montréal,
St-Hyacinthe, Québec J2S 7C6, Canada
Received 21 May 1999/Returned for modification 19 July
1999/Accepted 9 September 1999
 |
ABSTRACT |
Streptococcus agalactiae is considered one of the major
causes of bovine intramammary infections. It is also found in the vaginas of women without any apparent clinical symptoms, but reports of
neonatal infections, causing significant morbidity, are relatively frequent. The aim of this study was to evaluate the genetic diversity of S. agalactiae strains isolated from bovine milk and from
asymptomatic women in Québec, Canada, by randomly amplified
polymorphic DNA (RAPD) analysis. A total of 185 bovine isolates and 38 human isolates were first serotyped for capsular polysaccharide by
double diffusion in agarose gel (bovine isolates) and coagglutination
(human isolates). Strains were then studied by RAPD using 3 primers,
designated OPS11, OPB17, and OPB18, which were selected from 12 primers. Thirty-eight percent of bovine isolates and 82% of human
isolates could be serotyped. Prevalent serotypes were type III (28%)
for bovine isolates and types V (26%) and III (24%) for human
isolates. RAPD results showed that, taken together, all isolates (of
bovine and human origin) shared 58% similarity. Ninety-four percent of these isolates were clustered in four groups (I, II, III, and IV) with
70% similarity among them. Three clusters, A (48 isolates), B (14 isolates), and C (32 isolates), with 79 to 80% similarity were
identified within group IV, whereas the three other groups did not
present any clusters. Despite some clustering of human isolates,
relatively high diversity was seen among them. Relatively high
heterogeneity was observed with the RAPD profiles, not only for field
strains belonging to different serotypes but also for those within a
given serotype.
 |
INTRODUCTION |
Mastitis remains one of the most
economically important problems of the dairy cattle industry throughout
the world. Milk quality and the prevalence of clinical and subclinical
mastitis are major factors in determining farm profitability
(16).
Streptococcus agalactiae (Lancefield group B) is a highly
contagious obligate parasite of the mammary gland, where it can survive
for long periods of time (19). Since this organism is susceptible to treatment with a variety of antimicrobial agents, eradication within a closed herd is possible. With increasing pressures
for the reduction of antimicrobial agents in animals as well as in
humans, the necessity for improved understanding of the epidemiology of
this etiological agent has become apparent (1). Prevalence
studies for S. agalactiae in cattle have been conducted in
different areas of North America (19, 20, 31). Data about
the epidemiology and molecular characteristics of this organism from
bovine milk are not available in Canada. In the United States, only a
few studies, with a limited number of strains, have been carried out on
these subjects (7, 29).
S. agalactiae also causes significant morbidity and
mortality in humans, both infants and adults, worldwide (3).
In neonates, S. agalactiae is mostly acquired from the
mother's vagina in early-onset disease, although nosocomial,
community, and breast milk transmissions have been reported
(2). In adults, S. agalactiae occurs
preferentially in certain individuals, such as diabetics, pregnant and
postpartum women, and immunocompromised patients, emphasizing the
opportunistic nature of the infection (23). Furthermore,
humans act as a significant reservoir of S. agalactiae,
since this bacterium may be carried in the vaginas of women without
apparent clinical signs (14). Questions have been raised as
to whether S. agalactiae is a zoonotic agent or whether
host-specific ecovars exist. Controversial reports indicate the absence
or the presence of a relationship between human and bovine S. agalactiae isolates (8, 18). Some epidemiological studies on S. agalactiae infections have been based on
serotyping techniques, but these traditional procedures are limited in
that their discriminatory potential is too low. DNA-based subtyping techniques, such as pulsed-field gel electrophoresis (PFGE)
(10), ribotyping (5), restriction enzyme analysis
(REA) (9), multilocus enzyme electrophoresis
(28), and random amplification of polymorphic DNA (RAPD)
(6) have been used efficaciously to subtype S. agalactiae isolates of human origin. Methodologies such as
ribotyping and PFGE usually involve time-consuming steps and/or
sophisticated equipment. REA has the advantages of simplicity and high
discriminatory power but is sometimes difficult to interpret because of
the large number of restriction fragments generated. RAPD is an
accessible and sensitive method based on the use of arbitrary primers
to amplify polymorphic segments of DNA. This technique has been widely used in recent years for detection of diversity among isolates (25, 34, 36).
The objective of this work was to study, by RAPD, the genetic diversity
of a collection of S. agalactiae isolates originating from
dairy cattle in different parts of Québec, Canada. Data were used
to standardize the technique and evaluate the discriminatory power of
the primers used. In addition, some isolates from asymptomatic healthy
women were also analyzed and compared to bovine isolates.
 |
MATERIALS AND METHODS |
Bacteria.
Reference strains of S. agalactiae
serotypes Ia (SS 615), Ib (SS 618), II (SS
619), III (SS620), IV (3139), and V (SS 1169 [NT1]) were used as
positive controls in serotyping and RAPD experiments. All reference
strains originated from the Centers for Disease Control and Prevention,
Atlanta, Ga., except for S. agalactiae serotype IV (3139),
which was kindly sent by J. Henrichsen, Statens Serum Institut,
Copenhagen, Denmark.
A total of 297 bovine isolates were collected in cases of bovine
mastitis or from a bulk tank of unrelated herds by the seven provincial
laboratories of Québec, Canada, during 1996 and 1997. All
agricultural regions of Québec were represented. In addition, 38 S. agalactiae isolates were collected from vaginal or rectal swabs of asymptomatic pregnant women. These isolates originated from
two different geographical regions (representing 29 and 9 isolates,
respectively). S. agalactiae was isolated by using
Trypticase soy agar supplemented with 5% sheep blood. All isolates
were identified as S. agalactiae based on a positive
Christie, Atkins, and Munch-Peterson (CAMP) reaction, lack of esculin
hydrolysis, and a positive latex agglutination test for Lancefield
group B (22). The latter test was conducted with a
commercial kit (Patho Dx; Diagnostic Products Corporation)
according to the manufacturer's recommendations.
Serotyping.
Human isolates were serotyped on the basis of
capsular polysaccharides by the coagglutination method (21).
Since most bovine isolates were autoagglutinable, they were serotyped
by double diffusion in agarose gels (17). Anti-type
Ia, Ib, II, III, IV, and V sera were purchased
from Oxoid (Basingstoke, England).
RAPD fingerprinting.
All human isolates and 185 representative bovine isolates were analyzed by RAPD. This analysis was
performed as described by Williams et al. (36) with some
modifications. The PCR mixture consisted of buffer (10 mM Tris-HCl [pH
8.3], 50 mM KCl; 2.5 mM MgCl2), 100 µM each of the four
deoxynucleoside triphosphates (Pharmacia Biotech Inc., Baie
d'Urfé, Québec, Canada), 0.4 µM primer, 50 ng of DNA
extracted and purified as previously described (27), and 2.5 U of Taq DNA polymerase (Pharmacia) in a total volume of 25 µl. The primers used are shown in Table 1 and were synthesized by
Gibco BRL Custom Primers (Burlington, Ontario, Canada). Each sample was
subjected to the first cycle of denaturation (5 min at 94°C) in a DNA
Thermal Cycler 480 (Perkin-Elmer Applied Biosystems, Foster City,
Calif.). Each of the 35 subsequent cycles consisted of denaturing at
94°C for 30 s, annealing at 35°C for 30 s, and extension
at 72°C for 1 min. The last cycle included an extension at 72°C for
5 min. Amplified products were separated by electrophoresis in a 1.4%
agarose gel (Sigma) and visualized as white bands on a black background
by UV transillumination following ethidium bromide staining. A 1-kb DNA
ladder (Gibco) was used in each gel as molecular size standards. A
negative control, consisting of the same reaction mixture but with
water instead of template DNA, was included in each run. In addition, a
positive control, containing the same reaction mixture with a template
of DNA from a well-characterized reference strain (S. agalactiae SS 615), was also included. Each isolate was tested
under the same conditions at least three times with the selected primers.
Pattern analysis.
Photographs of each gel were digitalized
with a video camera connected to a microcomputer (Alpha ease; Alpha
Innotech Corp., San Leandro, Calif.). After conversion, the data were
normalized and analyzed. Degrees of homology were determined by Dice
comparisons, and clustering correlation coefficients were calculated by
the unweighted pair group method with arithmetic averages. When the calculations were completed, a dendrogram showing the hierarchic representation of linkage level between isolates was drawn. All these
processes were carried out with Molecular Analyst Software, Fingerprinting, version 1.12 (Bio-Rad Laboratories, Mississauga, Ontario, Canada).
Discriminatory analysis.
The probability that two unrelated
isolates sampled from the test population will be placed into different
typing groups or clusters was assessed according to the Hunter-Gaston
formula (15). This probability is calculated as
where
N is the total number of isolates in the sample
population,
s is the total number of Rapid's patterns
described, and
nj is the number of isolates
belonging to the
jth
type.
 |
RESULTS |
Identification of informative primers.
To identify primers
that generate informative arrays of PCR products, eight unrelated
S. agalactiae isolates were selected from the entire panel
of isolates. They had been isolated from different geographic sites and
belonged to different serotypes or were nontypeable (Fig.
1).

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 1.
Illustration of the RAPD patterns generated with primers
OPS11, OPB17, and OPB18. Lanes 1, reference strain SS615 (serotype
Ia); lanes 2 nontypeable bovine isolate from region 3;
lanes 3, serotype III bovine isolate from region 2; lanes 4, serotype
III bovine isolate from region 7; lanes 5, serotype IV human isolate
from region 4; lanes 6, serotype II bovine isolate from region 6; lanes
7, serotype V human isolate from region 4; lanes 8, serotype
Ib bovine isolate from region 2; lanes M, 1-kb DNA ladder
(DNA molecular size marker).
|
|
Twelve oligonucleotides, each 10 nucleotides long, with a G+C content
of 40 to 70%, and containing no palindromic sequences,
were tested
(Table
1). The choice of selected primers
was based
on the number of bands generated (with as few low-intensity
bands
as possible) as well as the quantity of different and
reproducible
patterns yielded. Three primers (OPS11, OPB17, and OPB18)
were
selected because they satisfied the characteristics described
above (Fig.
1). A set of reproducible bands produced for a particular
primer was defined as a "pattern".
Serotyping.
The double diffusion method was used to serotype
bovine isolates because most of them were autoagglutinable. However,
nonagglutinable bovine isolates were analyzed by both methods with
identical results (data not shown). Results of serotyping for bovine
and human isolates can be observed in Table
2. Sixty-two percent of bovine isolates were nontypeable. The remaining bovine isolates were found to belong to
four different serotypes. Serotype III was the most prevalent,
representing 28% of all bovine isolates. All six serotypes tested were
identified among the 38 human isolates (Table 2). Only five human
isolates were nontypeable and two autoagglutinated. Serotypes V and III
were the most frequently identified serotypes, with prevalences of 26 and 24%, respectively.
Genetic diversity as defined by RAPD fingerprinting.
The
genetic relationship among all RAPD patterns of S. agalactiae based on the combination of data obtained with the
three primers is represented in the dendrogram shown in Fig.
2. Overall, S. agalactiae isolates presented 58% similarity. A
total of 94% of the isolates were clustered in four groups (I, II,
III, and IV) with 70% similarity among them. Three clusters, A (48 isolates), B (14 isolates), and C (32 isolates), with 79 to 80%
similarity, were identified within group IV. The other three groups did
not present any clustering. The percent similarity of each group
oscillated between 70 and 77%. The heterogeneity of the population was
significantly increased by 14 nongrouped isolates.


View larger version (2734K):
[in this window]
[in a new window]
|
FIG. 2.
Genetic relationship among 223 S. agalactiae
isolates (of bovine and human origins) as estimated by clustering
analysis of RAPD patterns obtained with three primers. The dendrogram
was generated by the unweighted pair group method with arithmetic
means. H, carrier woman; B, bovine milk; UT, untypeable; AA,
autoagglutinable.
|
|
Genetic variation in relation to serotype.
The serotype
distribution for each RAPD pattern is indicated in Fig. 2. In addition,
the relationship between serotype and RAPD group and/or cluster is also
observed in Tables 3 and
4 for isolates of bovine and human
origin, respectively. Half of serotype III and II isolates of bovine
origin were in group II. Nontypeable bovine isolates were
proportionally distributed in all groups (Table 3). All serotype
Ia isolates and most serotype III isolates recovered from
humans were in cluster C. Most human isolates of serotype V were
included in group I (Table 4). Clustering was not observed for other
serotypes.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Distribution of S. agalactiae isolates of
bovine origin in different RAPD groups and/or clusters according to
capsular serotypea
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Distribution of S. agalactiae isolates of
human origin in different RAPD groups and/or clusters according to
capsular serotypea
|
|
Genetic variation of isolates in relation to geographical
distribution.
In general, clustering was not observed for bovine
isolates originating from the same region, except for those from
regions 1 and 2 (Fig. 2). In spite of the existing diversity, it was
possible to find at least one pair of isolates sharing the same RAPD
pattern in most of the regions.
Genetic variation of isolates in relation to host origin.
In
general, clustering was observed in most S. agalactiae
isolates of human origin (Fig. 2). Fifty percent of human isolates were
placed in cluster C of group IV, and 37% belonged to group I. The
human isolates were then analyzed separately to verify this apparently
high homology. Figure 3 shows relatively
high variability among human isolates, since only 65% similarity was found. A principal group (group ii), in which approximately 79% of
isolates clustered, and one minor group (group i) can be observed (Fig.
3). Two clusters, "a" (9 isolates) and "b" (21 isolates), with
80 to 82% similarity, were identified within group ii. The other group
did not present any clear cluster. The percent similarity of each group
oscillated between 76 and 77%. None of the human isolates shared
identical RAPD patterns with the three primers. In addition, in the
dendrogram illustrating the cluster analysis of S. agalactiae isolated from asymptomatic women, most isolates of
serotype V appeared in cluster "a" (Fig. 3). This confirmed results
obtained with the general dendrogram that included the analysis of
bovine and human isolates (Fig. 2).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Genetic relationship among 38 S. agalactiae
isolates from asymptomatic pregnant women as estimated by cluster
analysis of RAPD patterns obtained with three primers. The dendrogram
was generated by the unweighted pair group method with arithmetic
means. UT, untypeable; AA, autoagglutinable.
|
|
Identical RAPD patterns (for the combination of the three primers)
between human and bovine isolates were observed only in
one case (Fig.
2). The isolate of human origin belonged to serotype
V, whereas the
isolate of bovine origin was nontypeable; both
of them were placed in
group I of the
dendrogram.
RAPD typing as an epidemiological tool.
The discriminatory
capacity of the RAPD typing was determined in order to evaluate the
suitability of the primers chosen in this study for the epidemiological
analysis of S. agalactiae isolated from milk. It was
possible to define 215 RAPD types for the 223 isolates (index of
discrimination [D] = 0.9996) by combining data obtained
with the three primers, whereas only seven serotypes for the 223 isolates (D = 0.6908) were identified by serotyping.
 |
DISCUSSION |
Limited information was available on the epidemiology of Canadian
S. agalactiae isolates recovered from bovine milk. To our knowledge, few studies using DNA-based techniques have been carried out
with a large collection of field isolates of bovine origin in North
America. Previous studies on S. agalactiae isolates of human
origin have suggested that RAPD is superior to serotyping for
epidemiological evaluations of this pathogen (6, 24). In the
present work, RAPD was used to study a large collection of bovine
isolates from Canada. In general, high genetic diversity was found. A
possible explanation for this diversity is that different isolates
originated from different herds. Similar results were obtained by using
other molecular techniques in Australia, Denmark, and the United
States, even though these studies were based on lower numbers of herds
and field strains (1, 18, 29).
S. agalactiae can be differentiated on the basis of distinct
polysaccharide surface antigens. In this study, as in others (4,
11), most bovine isolates were nontypeable by polysaccharide antigens. Only 38% of isolates of bovine origin were typeable; serotype III was the most important. Previous studies showed a relative
heterogeneity in the distribution of different serotypes of bovine
isolates (4, 18, 26, 35). The importance of invasive
serotype III strains is well known among human isolates (28), but the significance for bovine isolates is unknown yet.
In general, no evident correlation could be established between
serotyping and RAPD patterns. Before this study, data which combine
genomic diversity and antigenic typing were not available for bovine
isolates. Results showed genetic heterogeneity not only among different
serotypes but also among isolates belonging to same serotype. This
suggests that the RAPD technique may be more accurate than capsular
serotyping in differentiating S. agalactiae isolates from a
bovine population. RAPD of S. agalactiae of bovine origin
therefore appears to be of great value for epidemiological studies.
Clustering was not observed for bovine isolates originating from the
same region, except for those from regions 1 and 2. This result is
consistent with a previous report of Rivas et al. (29), who
analyzed S. agalactiae of bovine origin by automated
ribotyping. They could not find one ribotype in all three regions
delineated in New York State. In the present study, at least two
isolates with an identical RAPD pattern were found in each region. This fact might suggest that, in some instances, there may be a common source of S. agalactiae in different herds from the same region.
The serotype distribution of S. agalactiae of human origin
appears to have changed over time. Until recently, the predominant serotypes that were detected among clinical isolates by the Centers for
Disease Control and Prevention and other laboratories were Ia and III (3, 13, 14). A striking change,
however, occurred in the 1990s, when the percentage of serotype V
climbed from 2.6% in 1992 to 14% in 1993 and then to 20% in 1994 (12). The reasons for this increase are still unclear.
Interestingly, serotypes V and III were identified in the present study
as the most frequent serotypes among isolates from carrier women, with
prevalences of 26 and 24%, respectively.
Reports on the genetic diversity of S. agalactiae isolated
from healthy women are controversial. Huet et al. concluded that the
genetic polymorphism of isolates from carrier women, as evaluated by
ribotyping, is relatively limited (14). However, this
technique appears to have low discriminatory power when it is used
alone for epidemiological studies of S. agalactiae
(14). On the other hand, Helmig et al. observed considerable
heterogeneity in a population of S. agalactiae isolates from
asymptomatic women (13). In agreement with other studies
(7, 33), data presented here indicate that isolates from
asymptomatic women have a slightly closer relationship than isolates of
bovine origin. In spite of some clustering of human isolates,
relatively high diversity was seen among them.
In this study, only one pair of human (serotype V) and bovine
(nontypeable) isolates showing the same RAPD pattern was found. This
suggests the possibility of a common origin for both isolates. This is
in agreement with the results of Jensen and Aarestrup, who detected
identical ribotypes for isolates from milk and dairy workers
(18). Despite the fact that a common source of human and
bovine isolates is possible (18), results obtained in this work do not allow confirmation of this hypothesis. Isolates belonging to different serotypes but indistinguishable by genetic analysis have
already been described (2, 18). One possible explanation is
the ability of S. agalactiae to regulate capsule expression in a phase shift-like manner (32). The ability to phase
shift may be of particular interest in S. agalactiae
mastitis, since bacterial adherence is an important factor in the
pathogenesis of bovine mastitis, and the adhesion of S. agalactiae to epithelial cells seems to be inversely proportional
to the degree of encapsulation (30).
The selection of primers is critical in maximizing the discriminatory
power of RAPD typing. An index of discrimination (D) greater
than 0.90 is necessary for interpreting typing results with confidence
(15). Two previous studies have reported genetic analysis of
S. agalactiae isolates of human origin by RAPD (6, 24). In one of those studies, a partially degenerated
oligonucleotide with a D of 0.98 was used (24),
whereas in the other, a combination of four primers with a D
of 0.90 was obtained (6). Our data suggest that the RAPD
typing generated by the combination of OPS11, OPB17, and OPB18 primers
(D = 0.9996) has increased the ability of the
methodology to detect variability between isolates. Potential applications include identification of isolates that appear to have
broad geographic distribution, suggesting interfarm transfer, and
discrimination among recurrent versus new intramammary infections. Such
information may allow the establishment of control and eradication programs at the herd level. Furthermore, RAPD typing may be used to
study the relationship between human and bovine infection.
 |
ACKNOWLEDGMENTS |
We thank the different provincial laboratories of Québec
for providing the isolates of bovine origin. We are also indebted to
Philippe Jutras (Centre Hospitalier de Rimouski) and Monique Goyette
(Hôpital Saint-Joseph, Trois-Rivières) for the group B
Streptococcus isolates of human origin.
This work was supported by a grant from NSERC-RII (195831-96) and the
Dairy Farmers of Canada.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Groupe de
Recherche sur les Maladies Infectieuses du Porc, Département
de Pathologie et Microbiologie, Faculté de médecine
vétérinaire, Université de Montréal, C.P. 5000, St-Hyacinthe, Québec J2S 7C6, Canada. Phone: (450) 773-8521, ext.
8374. Fax: (450) 778-8108. E-mail: gottschm{at}medvet.umontreal.ca.
 |
REFERENCES |
| 1.
|
Baseggio, N.,
P. D. Mansell,
J. W. Browning, and G. F. Browning.
1997.
Strain differentiation of isolates of streptococci from bovine mastitis by pulsed-field gel electrophoresis.
Mol. Cell. Probes.
11:349-354[CrossRef][Medline].
|
| 2.
|
Bingen, E.,
E. Denamur,
N. Lambert-Zechovsky,
Y. Aujard,
N. Brahimi,
P. Geslin, and J. Elion.
1992.
Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection.
J. Infect. Dis.
165:569-573[Medline].
|
| 3.
|
Blumberg, H. M.,
D. S. Stephens,
C. Licitra,
N. Pigott,
R. Facklam,
B. Swaminathan, and I. K. Wachsmuth.
1992.
Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping).
J. Infect. Dis.
166:574-579[Medline].
|
| 4.
|
Bopp, V., and C. Lammler.
1995.
Comparative studies on group-B streptococci isolated from bovine milk samples in Thuringia and Hesse.
Zentbl. Veterinarmed. B
42:427-433.
|
| 5.
|
Chatellier, S.,
H. Huet,
S. Kenzi,
A. Rosenau,
P. Geslin, and R. Quentin.
1996.
Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis.
J. Clin. Microbiol.
34:2741-2747[Abstract].
|
| 6.
|
Chatellier, S.,
C. Ramanantsoa,
P. Harriau,
K. Rolland,
A. Rosenau, and R. Quentin.
1997.
Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis.
J. Clin. Microbiol.
35:2573-2579[Abstract].
|
| 7.
|
Denning, D. W.,
C. J. Baker,
N. J. Troup, and L. S. Tompkins.
1989.
Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study.
J. Clin. Microbiol.
27:1352-1356[Abstract/Free Full Text].
|
| 8.
|
Devriese, L. A.
1991.
Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes.
J. Appl. Bacteriol.
71:478-483[Medline].
|
| 9.
|
Ellis, S.,
M. Kotiw, and S. M. Garland.
1996.
Restriction endonuclease analysis of group B streptococcal isolates from two distinct geographical regions.
J. Hosp. Infect.
33:279-287[CrossRef][Medline].
|
| 10.
|
Fasola, E.,
C. Livdahl, and P. Ferrieri.
1993.
Molecular analysis of multiple isolates of the major serotypes of group B streptococci.
J. Clin. Microbiol.
31:2616-2620[Abstract/Free Full Text].
|
| 11.
|
Finch, L. A., and D. R. Martin.
1984.
Human and bovine group B streptococci: two distinct populations.
J. Appl. Bacteriol.
57:273-278[Medline].
|
| 12.
|
Harrison, L. H.,
D. M. Dwyer, and J. A. Johnson.
1995.
Emergence of serotype V group B streptococcal infection among infants and adults.
J. Infect. Dis.
171:513[Medline].
|
| 13.
|
Helmig, R.,
N. Uldbjerg,
J. Boris, and M. Kilian.
1993.
Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women.
J. Infect. Dis.
168:904-909[Medline].
|
| 14.
|
Huet, H.,
C. Martin,
P. Geslin,
F. Grimont, and R. Quentin.
1993.
Ribotyping of Streptococcus agalactiae strains isolated from vaginas of asymptomatic women.
Res. Microbiol.
144:457-465[Medline].
|
| 15.
|
Hunter, P. R., and M. A. Gaston.
1988.
Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.
J. Clin. Microbiol.
26:2465-2466[Abstract/Free Full Text].
|
| 16.
|
Janzen, J. J.
1970.
Economic losses resulting from mastitis. A review.
J. Dairy Sci.
53:1151-1161.
|
| 17.
|
Jensen, N. E.
1979.
Production and evaluation of antisera for serological type determination of group B streptococci by double diffusion in agarose gel.
Acta Pathol. Microbiol. Scand. Sect B.
87:77-83.
|
| 18.
|
Jensen, N. E., and F. M. Aarestrup.
1996.
Epidemiological aspects of group B streptococci of bovine and human origin.
Epidemiol. Infect.
117:417-422[Medline].
|
| 19.
|
Keefe, G. P.
1997.
Streptococcus agalactiae mastitis: a review.
Can. Vet. J.
38:429-437[Medline].
|
| 20.
|
Keefe, G. P.,
I. R. Dohoo, and E. Spangler.
1997.
Herd prevalence and incidence of Streptococcus agalactiae in the dairy industry of Prince Edward Island.
J. Dairy Sci.
80:464-470[Abstract].
|
| 21.
|
Kirkegaard, M. K., and C. R. Field.
1977.
Rapid slide coagglutination test for identifying and typing group B streptococci.
J. Clin. Microbiol.
6:266-270[Abstract/Free Full Text].
|
| 22.
|
Lancefield, R. C.
1934.
Serologic differentiation of specific types of bovine hemolytic streptococci (group B).
J. Exp. Med.
61:335-349.
|
| 23.
|
Lerner, P.,
K. Gopalakrishna,
E. Wolinsky,
M. D. McHenry,
J. S. Tan, and M. Rosenthal.
1977.
Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature.
Medicine
56:457-473[Medline].
|
| 24.
|
Limansky, A. S.,
E. G. Sutich,
M. C. Guardati,
I. E. Toresani, and A. M. Viale.
1998.
Genomic diversity among Streptococcus agalactiae isolates detected by a degenerate oligonucleotide-primed amplification assay.
J. Infect. Dis.
177:1308-1313[Medline].
|
| 25.
|
Maslow, J. N.,
M. E. Mulligan, and R. D. Arbeit.
1993.
Molecular epidemiology: application of contemporary techniques to the typing of microorganisms.
Clin. Infect. Dis.
17:153-164[Medline].
|
| 26.
|
Mosabi, J. M.,
S. M. Arimi, and E. K. Kang'ethe.
1997.
Isolation and characterization of group B streptococci from human and bovine sources within and around Nairobi.
Epidemiol. Infect.
118:215-220[CrossRef][Medline].
|
| 27.
|
Pitcher, D. G.,
N. A. Saunders, and R. J. Owen.
1989.
Rapid extraction of bacterial genomic DNA with guanidium thiocyanate.
Lett. Appl. Microbiol.
8:151-156.
|
| 28.
|
Quentin, R.,
H. Huet,
F.-S. Wang,
P. Geslin,
A. Goudeau, and R. K. Selander.
1995.
Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease.
J. Clin. Microbiol.
33:2576-2581[Abstract].
|
| 29.
|
Rivas, A. L.,
R. N. Gonzalez,
M. Wiedmann,
J. L. Bruce,
E. M. Cole,
G. J. Bennett,
H. F. Schulte III,
D. J. Wilson,
H. O. Mohammed, and C. A. Batt.
1997.
Diversity of Streptococcus agalactiae and Staphylococcus aureus ribotypes recovered from New York dairy herds.
Am. J. Vet. Res.
58:482-487[Medline].
|
| 30.
|
Salasia, S. I. O.,
I. W. T. Wibawan,
C. Lammler, and M. Sellin.
1994.
Phase variation in streptococci of serological group B.
APMIS
102:925-930[Medline].
|
| 31.
|
Sargeant, J. M.,
H. Morgan Scott,
K. E. Leslie,
M. J. Ireland, and A. Bashiri.
1998.
Clinical mastitis in dairy cattle in Ontario: frequency of occurrence and bacteriological isolates.
Can. Vet. J.
39:33-38[Medline].
|
| 32.
|
Sellin, M.,
M. Linderholm,
M. Norgren, and S. Hakansson.
1992.
Endocarditis caused by a group B streptococcus strain, type III, in a nonencapsulated phase.
J. Clin. Microbiol.
30:2471-2473[Abstract/Free Full Text].
|
| 33.
|
Wanger, A. R., and G. M. Dunny.
1985.
Development of a system for genetic and molecular analysis of Streptococcus agalactiae.
Res. Vet. Sci.
38:202-208[Medline].
|
| 34.
|
Welsh, J., and M. McClelland.
1990.
Fingerprinting genomes using PCR with arbitrary primers.
Nucleic Acids Res.
18:7213-7218[Abstract/Free Full Text].
|
| 35.
|
Wibawan, I. W. T., and C. Lammler.
1990.
Properties of group B streptococci with protein surface antigens X and R.
J. Clin. Microbiol.
28:2834-2836[Abstract/Free Full Text].
|
| 36.
|
Williams, J. G. K.,
A. R. Kubelik,
K. J. Livak,
J. A. Rafalski, and S. V. Tingey.
1990.
DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.
Nucleic Acids Res.
18:6531-6535[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, January 2000, p. 71-78, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Strus, M., Pawlik, D., Brzychczy-Wloch, M., Gosiewski, T., Rytlewski, K., Lauterbach, R., Heczko, P. B.
(2009). Group B streptococcus colonization of pregnant women and their children observed on obstetric and neonatal wards of the University Hospital in Krakow, Poland. J Med Microbiol
58: 228-233
[Abstract]
[Full Text]
-
Evans, J. J., Bohnsack, J. F., Klesius, P. H., Whiting, A. A., Garcia, J. C., Shoemaker, C. A., Takahashi, S.
(2008). Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J Med Microbiol
57: 1369-1376
[Abstract]
[Full Text]
-
Kong, F., Lambertsen, L. M., Slotved, H.-C., Ko, D., Wang, H., Gilbert, G. L.
(2008). Use of Phenotypic and Molecular Serotype Identification Methods To Characterize Previously Nonserotypeable Group B Streptococci. J. Clin. Microbiol.
46: 2745-2750
[Abstract]
[Full Text]
-
Bohnsack, J. F., Whiting, A., Gottschalk, M., Dunn, D. M., Weiss, R., Azimi, P. H., Philips, J. B. III, Weisman, L. E., Rhoads, G. G., Lin, F.-Y. C.
(2008). Population Structure of Invasive and Colonizing Strains of Streptococcus agalactiae from Neonates of Six U.S. Academic Centers from 1995 to 1999. J. Clin. Microbiol.
46: 1285-1291
[Abstract]
[Full Text]
-
Slotved, H.-C., Kong, F., Lambertsen, L., Sauer, S., Gilbert, G. L.
(2007). Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J. Clin. Microbiol.
45: 2929-2936
[Abstract]
[Full Text]
-
Kong, F., Gidding, H. F., Berner, R., Gilbert, G. L.
(2006). Streptococcus agalactiae C{beta} protein gene (bac) sequence types, based on the repeated region of the cell-wall-spanning domain: relationship to virulence and a proposed standardized nomenclature.. J Med Microbiol
55: 829-837
[Abstract]
[Full Text]
-
Dogan, B., Schukken, Y. H., Santisteban, C., Boor, K. J.
(2005). Distribution of Serotypes and Antimicrobial Resistance Genes among Streptococcus agalactiae Isolates from Bovine and Human Hosts. J. Clin. Microbiol.
43: 5899-5906
[Abstract]
[Full Text]
-
Sukhnanand, S., Dogan, B., Ayodele, M. O., Zadoks, R. N., Craver, M. P. J., Dumas, N. B., Schukken, Y. H., Boor, K. J., Wiedmann, M.
(2005). Molecular Subtyping and Characterization of Bovine and Human Streptococcus agalactiae Isolates. J. Clin. Microbiol.
43: 1177-1186
[Abstract]
[Full Text]
-
Duarte, R. S., Bellei, B. C., Miranda, O. P., Brito, M. A. V. P., Teixeira, L. M.
(2005). Distribution of Antimicrobial Resistance and Virulence-Related Genes among Brazilian Group B Streptococci Recovered from Bovine and Human Sources. Antimicrob. Agents Chemother.
49: 97-103
[Abstract]
[Full Text]
-
Thong, K.-L., Ling, G. Y., Kong, L. W., Theam, L. C., Ngeow, Y. F.
(2004). Macrorestriction analysis of Streptococcus agalactiae (group B Streptococcus) isolates from Malaysia. J Med Microbiol
53: 991-997
[Abstract]
[Full Text]
-
Duarte, R. S., Miranda, O. P., Bellei, B. C., Brito, M. A. V. P., Teixeira, L. M.
(2004). Phenotypic and Molecular Characteristics of Streptococcus agalactiae Isolates Recovered from Milk of Dairy Cows in Brazil. J. Clin. Microbiol.
42: 4214-4222
[Abstract]
[Full Text]
-
Bisharat, N., Crook, D. W., Leigh, J., Harding, R. M., Ward, P. N., Coffey, T. J., Maiden, M. C., Peto, T., Jones, N.
(2004). Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor. J. Clin. Microbiol.
42: 2161-2167
[Abstract]
[Full Text]
-
Kong, F., Martin, D., James, G., Gilbert, G. L.
(2003). Towards a genotyping system for Streptococcus agalactiae (group B streptococcus): use of mobile genetic elements in Australasian invasive isolates. J Med Microbiol
52: 337-344
[Abstract]
[Full Text]
-
Ravelo, C., Magarinos, B., Lopez-Romalde, S., Toranzo, A. E., Romalde, J. L.
(2003). Molecular Fingerprinting of Fish-Pathogenic Lactococcus garvieae Strains by Random Amplified Polymorphic DNA Analysis. J. Clin. Microbiol.
41: 751-756
[Abstract]
[Full Text]